Euromonitor International and IRIS Ventures identify a robust market surge for longevity-driven supplements, while L’Oréal’s Longevity Integrative Science division leverages epigenomic testing and its AI-powered Longevity Cloud to tailor topical and ingestible beauty interventions. Brands like ARTIS London and Niance are integrating NAD+, NMN and postbiotic compounds such as urolithin A into their formulations to support cellular health, reflecting a shift toward healthspan optimization through combined nutritional, molecular and digital approaches.

Key points

• Euromonitor International reports global vitamins and supplement sales hitting $139.9 billion by 2025, driven by longevity-focused “healthspan” consumers.
• IRIS Ventures highlights key supplements (vitamin D, magnesium, curcumin, ashwagandha, NMN) targeting metabolic health, muscle maintenance and cognitive function across age groups.
• L’Oréal’s Longevity Integrative Science division maps 267 epigenetic biomarkers via its AI-powered Cloud to tailor three stage-specific skin health interventions.
• Swiss biotech Timeline and EPFL’s Mitopure urolithin A postbiotic activates mitophagy, improving mitochondrial function, skin hydration and collagen gene expression.
• ARTIS London and Niance integrate NAD+ precursors and sirtuin activators in oral supplements, signaling a shift toward hybrid beauty-wellness formulations.